Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference

Fig. 4

For all patients NTCP values for bladder and rectum were presented for all plans. The middle bars represent the mean values and the upper and lower bars the standard deviations. Wilcoxon matched pairs signed-rank test showed that no significant differences in NTCP values for the different Plans when dose was delivered in analogy to the Pinkawa protocol (p > 0.05). When dose was delivered in analogy to the Flame trial a significant reduction in NTCP-rectum values was observed for Plan95MRI compared to Plan95union (p = 0.012) and Plan95PET (p = 0.047). There were no significant differences in NTCP-bladder values for Plan95 (p > 0.05)

Back to article page